We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Enzon Pharmaceuticals, Inc. is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value. Enzon Pharmaceuticals, Inc. is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00515 | 7.24331926864 | 0.0711 | 0.082 | 0.0711 | 9727 | 0.07262912 | CS |
4 | -0.01375 | -15.2777777778 | 0.09 | 0.09 | 0.071 | 12104 | 0.0771022 | CS |
12 | -0.0688 | -47.4319200276 | 0.14505 | 0.1486 | 0.0699 | 18004 | 0.10023842 | CS |
26 | -0.05375 | -41.3461538462 | 0.13 | 0.24 | 0.0699 | 23818 | 0.14710239 | CS |
52 | -0.02375 | -23.75 | 0.1 | 0.24 | 0.06 | 24505 | 0.12154067 | CS |
156 | -0.29875 | -79.6666666667 | 0.375 | 0.4788 | 0.06 | 28363 | 0.24289956 | CS |
260 | -0.15575 | -67.1336206897 | 0.232 | 0.8599 | 0.02 | 58755 | 0.33871527 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions